138 results on '"Hassan, A. Bassim"'
Search Results
2. Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
3. Id1,Spp1andPak3are biomarkers ofSmad4and TGF-β1 dependency in conditional intestinal adenoma, organoids and colorectal cancer.
4. Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
5. Cost-effectiveness of healthcare interventions for rare cancers: Evidence from a systematic literature review and meta-analysis
6. Mapping Wnt/β-Catenin Signaling during Mouse Development and in Colorectal Tumors
7. New indicators and indexes for benchmarking university–industry–government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project
8. Supplementary Figure Legends and Tables 1-2 from Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting
9. Supplementary Figure 3 from Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting
10. Supplementary Figures 1 and 2 from Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting
11. Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist
12. Visualization of replication and transcription sites in human cells
13. Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2rI1565A) results in partial lethality, overgrowth and intestinal adenoma progression
14. Retrospective audit of 957 consecutive 18F-FDG PET–CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma
15. Additional file 1 of Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
16. Additional file 1 of Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients
17. Additional file 2 of Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
18. An Exon Splice Enhancer Primes IGF2:IGF2R Binding Site Structure and Function Evolution
19. A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
20. Structure of the Human Cation-Independent Mannose 6-Phosphate/IGF2 Receptor Domains 7–11 Uncovers the Mannose 6-Phosphate Binding Site of Domain 9
21. 217 - Bone tumors
22. Visualization of replication factories attached to a nucleoskeleton
23. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
24. Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
25. Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer
26. A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).
27. Structural and Stratigraphic 3D Seismic Study of NahrUmr and Zubair Formations in Kifl oil field _ center of Iraq
28. Contributors
29. Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent
30. A germline mutation of CDKN2A and a novel RPLP1-C19MC fusion detected in a rare melanotic neuroectodermal tumor of infancy: a case report
31. Sclerostin expression in bone tumours and tumour-like lesions
32. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
33. Pseudoligosita babylonica n. sp. (Hymenoptera: Trichogrammatidae), egg parasitoid of Ommatissus lybicus Bergevin (Homoptera: Tropiduchidae) in Iraq
34. Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis
35. Abstract A246: Development of an IGF2 super-antagonist by directed evolution of IGF2R.
36. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
37. An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
38. Maternal Transmission of a Humanised Igf2r Allele Results in an Igf2 Dependent Hypomorphic and Non-Viable Growth Phenotype
39. Igf2pathway dependency of theTrp53developmental and tumour phenotypes
40. An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
41. IGF signaling directs ventricular cardiomyocyte proliferation during embryonic heart development
42. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth
43. Structure and functional analysis of the IGF-II/IGF2R interaction
44. Structural Insights into the Interaction of Insulin-like Growth Factor 2 with IGF2R Domain 11
45. Allometric growth ratios are independent of Igf2 gene dosage during development
46. Functional evaluation of novel soluble insulin-like growth factor (IGF)-II–specific ligand traps based on modified domain 11 of the human IGF2 receptor
47. Soluble IGF2 Receptor Rescues Apc Min/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting
48. Keys to the Hidden Treasures of the Mannose 6-Phosphate/Insulin-Like Growth Factor 2 Receptor
49. Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model
50. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.